ONCY
Price:
$1.14
Market Cap:
$122.00M
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep in combination with paclitaxel and avelumab, a human anti-PD-L1 antibody for the treatment of hormone receptor-positive/human epidermal growth factor 2-negative metastatic breast cancer; and PrECOG LLC. The company was incorporated in 1998 and is headquartered in Calgar...[Read more]
Industry
Biotechnology
IPO Date
2001-10-05
Stock Exchange
NASDAQ
Ticker
ONCY
According to Oncolytics Biotech Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 100.82M. This represents a change of -6.08% compared to the average of 107.35M of the last 4 quarters.
The mean historical Enterprise Value of Oncolytics Biotech Inc. over the last ten years is 65.93M. The current 100.82M Enterprise Value has changed 15.19% with respect to the historical average. Over the past ten years (40 quarters), ONCY's Enterprise Value was at its highest in in the December 2019 quarter at 207.87M. The Enterprise Value was at its lowest in in the September 2019 quarter at 5.39M.
Average
65.93M
Median
67.43M
Minimum
18.11M
Maximum
123.09M
Discovering the peaks and valleys of Oncolytics Biotech Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 375.98%
Maximum Annual Enterprise Value = 123.09M
Minimum Annual Increase = -68.25%
Minimum Annual Enterprise Value = 18.11M
Year | Enterprise Value | Change |
---|---|---|
2023 | 87.07M | -25.45% |
2022 | 116.79M | 118.64% |
2021 | 53.42M | -41.71% |
2020 | 91.65M | -25.54% |
2019 | 123.09M | 375.98% |
2018 | 25.86M | -68.25% |
2017 | 81.44M | 272.34% |
2016 | 21.87M | 20.78% |
2015 | 18.11M | -54.71% |
2014 | 39.98M | -64.47% |
The current Enterprise Value of Oncolytics Biotech Inc. (ONCY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
85.76M
5-year avg
94.40M
10-year avg
65.93M
Oncolytics Biotech Inc.’s Enterprise Value is less than scPharmaceuticals Inc. (204.48M), less than Milestone Pharmaceuticals Inc. (118.83M), less than Seres Therapeutics, Inc. (278.81M), less than aTyr Pharma, Inc. (138.44M), less than DiaMedica Therapeutics Inc. (175.69M), less than Inhibikase Therapeutics, Inc. (172.46M), less than X4 Pharmaceuticals, Inc. (0), greater than Galera Therapeutics, Inc. (20.60M), greater than Terns Pharmaceuticals, Inc. (-6916978.00), less than Day One Biopharmaceuticals, Inc. (508.25M), less than HOOKIPA Pharma Inc. (1.07B), greater than CureVac N.V. (-26926933.00), less than Reata Pharmaceuticals, Inc. (395.31M), less than Krystal Biotech, Inc. (6.68B), less than Vir Biotechnology, Inc. (4.54B), less than Propanc Biopharma, Inc. (1.02B), greater than null (1.13M),
Company | Enterprise Value | Market cap |
---|---|---|
204.48M | $201.62M | |
118.83M | $78.84M | |
278.81M | $137.42M | |
138.44M | $131.12M | |
175.69M | $189.37M | |
172.46M | $175.37M | |
0 | $89.59M | |
20.60M | $2.64M | |
-6916978.00 | $599.50M | |
508.25M | $1.49B | |
1.07B | $45.33M | |
-26926933.00 | $607.87M | |
395.31M | $6.57B | |
6.68B | $4.91B | |
4.54B | $1.28B | |
1.02B | $206.41K | |
1.13M | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oncolytics Biotech Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Oncolytics Biotech Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Oncolytics Biotech Inc.'s Enterprise Value?
What is the highest Enterprise Value for Oncolytics Biotech Inc. (ONCY)?
What is the 3-year average Enterprise Value for Oncolytics Biotech Inc. (ONCY)?
What is the 5-year average Enterprise Value for Oncolytics Biotech Inc. (ONCY)?
How does the current Enterprise Value for Oncolytics Biotech Inc. (ONCY) compare to its historical average?